Literature DB >> 24582244

Silk fibroin porous scaffolds for nucleus pulposus tissue engineering.

Chao Zeng1, Qiang Yang1, Meifeng Zhu2, Lilong Du1, Jiamin Zhang2, Xinlong Ma3, Baoshan Xu4, Lianyong Wang5.   

Abstract

Intervertebral discs (IVDs) are structurally complex tissue that hold the vertebrae together and provide mobility to spine. The nucleus pulposus (NP) degeneration often results in degenerative IVD disease that is one of the most common causes of back and neck pain. Tissue engineered nucleus pulposus offers an alternative approach to regain the function of the degenerative IVD. The aim of this study is to determine the feasibility of porous silk fibroin (SF) scaffolds fabricated by paraffin-sphere-leaching methods with freeze-drying in the application of nucleus pulposus regeneration. The prepared scaffold possessed high porosity of 92.38±5.12% and pore size of 165.00±8.25μm as well as high pore interconnectivity and appropriate mechanical properties. Rabbit NP cells were seeded and cultured on the SF scaffolds. Scanning electron microscopy, histology, biochemical assays and mechanical tests revealed that the porous scaffolds could provide an appropriate microstructure and environment to support adhesion, proliferation and infiltration of NP cells in vitro as well as the generation of extracellular matrix. The NP cell-scaffold construction could be preliminarily formed after subcutaneously implanted in a nude mice model. In conclusion, The SF porous scaffold offers a potential candidate for tissue engineered NP tissue.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Intervertebral discs (IVD); Nucleus pulposus (NP); Porous scaffold; Silk fibroin; Tissue engineering

Mesh:

Substances:

Year:  2014        PMID: 24582244     DOI: 10.1016/j.msec.2014.01.012

Source DB:  PubMed          Journal:  Mater Sci Eng C Mater Biol Appl        ISSN: 0928-4931            Impact factor:   7.328


  8 in total

1.  Silk fibroin/collagen and silk fibroin/chitosan blended three-dimensional scaffolds for tissue engineering.

Authors:  Kai Sun; Hui Li; Ruixin Li; Zhenghao Nian; Dong Li; Cheng Xu
Journal:  Eur J Orthop Surg Traumatol       Date:  2014-08-14

Review 2.  Intervertebral disc tissue engineering: A brief review.

Authors:  Janja Stergar; Lidija Gradisnik; Tomaz Velnar; Uros Maver
Journal:  Bosn J Basic Med Sci       Date:  2019-05-20       Impact factor: 3.363

3.  Naringin-inlaid silk fibroin/hydroxyapatite scaffold enhances human umbilical cord-derived mesenchymal stem cell-based bone regeneration.

Authors:  Zhi-Hu Zhao; Xin-Long Ma; Bin Zhao; Peng Tian; Jian-Xiong Ma; Jia-Yu Kang; Yang Zhang; Yue Guo; Lei Sun
Journal:  Cell Prolif       Date:  2021-05-19       Impact factor: 6.831

4.  Intervertebral Disc Tissue Engineering with Natural Extracellular Matrix-Derived Biphasic Composite Scaffolds.

Authors:  Baoshan Xu; Haiwei Xu; Yaohong Wu; Xiulan Li; Yang Zhang; Xinlong Ma; Qiang Yang
Journal:  PLoS One       Date:  2015-04-20       Impact factor: 3.240

Review 5.  Development, Pathogenesis, and Regeneration of the Intervertebral Disc: Current and Future Insights Spanning Traditional to Omics Methods.

Authors:  Tara T Hickman; Sudiksha Rathan-Kumar; Sun H Peck
Journal:  Front Cell Dev Biol       Date:  2022-03-11

Review 6.  [Research progress of hydrogel used for regeneration of nucleus pulposus in intervertebral disc degeneration].

Authors:  Kun Shi; Yong Huang; Leizhen Huang; Jingcheng Wang; Yuhan Wang; Ganjun Feng; Limin Liu; Yueming Song
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2020-03-15

7.  Cell penetration and chondrogenic differentiation of human adipose derived stem cells on 3D scaffold.

Authors:  Rizka Musdalifah Amsar; Anggraini Barlian; Hermawan Judawisastra; Untung Ari Wibowo; Karina Karina
Journal:  Future Sci OA       Date:  2021-06-10

8.  The application of decellularized nucleus pulposus matrix/chitosan with transforming growth factor β3 for nucleus pulposus tissue engineering.

Authors:  Wenzhong Kuang; Chen Liu; Hongguang Xu
Journal:  Cytotechnology       Date:  2021-04-15       Impact factor: 2.040

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.